EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition

Jeonghwan Lee, Jinhaeng Lee, Kyuhong Kim, Jiwon Lee, Youngae Jung, Jin Seong Hyeon, Areum Seo, Wencheng Jin, Boram Weon, Nayeon Shin, Sejoong Kim, Chun Soo Lim und 4 weitere

Kidney International · 2024-06 · 105 (6) · 1239-1253

DOI: 10.1016/j.kint.2024.01.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024-06. Verfasst von Jeonghwan Lee und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Seoul Nati…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Anti-Bacterial Agents, Acute Kidney Injury, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intestinal microbiota and their metabolites affect systemic inflammation and kidney disease outcomes. Here, we investigated the key metabolites associated with the acute kidney injury (AKI)-to chronic kidney disease (CKD) transition and the effect of antibiotic-induced microbiota depletion (AIMD) on this transition. In 61 patients with AKI, 59 plasma metabolites were assessed to determine the risk of AKI-to-CKD transition. An AKI-to-CKD transition murine model was established four weeks after unilateral ischemia-reperfusion injury (IRI) to determine the effects of AIMD on the gut microbiome, metabolites, and pathological responses related to CKD transition. Human proximal tubular epithelial cells were challenged with CKD transition-related metabolites, and inhibitory effects of NADPH oxidase 2 (NOX2) signals were tested. Based on clinical metabolomics, plasma trimethylamine N-oxide (TMAO) was associated with a significantly increased risk for AKI-to-CKD transition [adjusted odds ratio 4.389 (95% confidence interval 1.106-17.416)]. In vivo, AIMD inhibited a unilateral IRI-induced increase in TMAO, along with a decrease in apoptosis, inflammation, and fibrosis. The expression of NOX2 and oxidative stress decreased after AIMD. In vitro, TMAO induced fibrosis with NOX2 activation and oxidative stress. NOX2 inhibition successfully attenuated apoptosis, inflammation, and fibrosis with suppression of G2/M arrest. NOX2 inhibition (in vivo) showed improvement in pathological changes with a decrease in oxidative stress without changes in TMAO levels. Thus, TMAO is a key metabolite associated with the AKI-to-CKD transition, and NOX2 activation was identified as a key regulator of TMAO-related AKI-to-CKD transition both in vivo and in vitro.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAnti-Bacterial AgentsAcute Kidney InjuryRenal Insufficiency, ChronicNADPH Oxidase 2MethylaminesHumansMaleFemaleMiddle AgedAgedAnimalsMiceMice, Inbred C57BLMetabolomicsReperfusion InjuryDisease Models, AnimalOxidative StressFibrosis

Stichwörter der Autor:innen

AKI-to-CKD transitionTMAOantibiotic-induced microbiota depletionkidney fibrosismicrobiotaoxidative stress

Substanzen

Anti-Bacterial AgentsCYBB protein, humanNADPH Oxidase 2trimethyloxamineMethylamines

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea; Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.

Förderung

  • Korea Ministry of Science and ICT

Zitieren

APA

Lee, J., Lee, J., Kim, K., Lee, J., Jung, Y., Hyeon, J. S., Seo, A., Jin, W., Weon, B., Shin, N., Kim, S., Lim, C. S., Kim, Y. S., Lee, J. P., Hwang, G. S., & Yang, S. H. (2024). Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney International, 105(6), 1239-1253. https://doi.org/10.1016/j.kint.2024.01.040

Vancouver

Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, et al. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney International. 2024;105(6):1239-1253. doi:10.1016/j.kint.2024.01.040

BibTeX
@article{Lee2024,
  author = {Lee, Jeonghwan and Lee, Jinhaeng and Kim, Kyuhong and Lee, Jiwon and Jung, Youngae and Hyeon, Jin Seong and Seo, Areum and Jin, Wencheng and Weon, Boram and Shin, Nayeon and Kim, Sejoong and Lim, Chun Soo and Kim, Yon Su and Lee, Jung Pyo and Hwang, Geum-Sook and Yang, Seung Hee},
  title = {Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition},
  journal = {Kidney International},
  year = {2024},
  volume = {105},
  number = {6},
  pages = {1239--1253},
  doi = {10.1016/j.kint.2024.01.040}
}
Kostenlos starten →